Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) announced that it has successfully completed its previously announced acquisition (the “Acquisition”) of US Compounding ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE